BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11692656)

  • 1. An appraisal of chemotherapy: in the blood or in the brain?
    Schmidt MH; Chang SM; Berger MS
    Clin Neurosurg; 2001; 48():46-59. PubMed ID: 11692656
    [No Abstract]   [Full Text] [Related]  

  • 2. Osmotic blood-brain barrier modification for the treatment of malignant brain tumors.
    Haluska M; Anthony ML
    Clin J Oncol Nurs; 2004 Jun; 8(3):263-7. PubMed ID: 15208820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood-brain barrier disruption controversy: does it hold water?
    Ruffer JE; Glatstein E
    Cancer J Sci Am; 1998; 4(2):84-5. PubMed ID: 9532409
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Goldstein DA; Tessler HH
    Am J Ophthalmol; 2007 Dec; 144(6):976; author reply 976. PubMed ID: 18036877
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Fortin D; Gendron C; Boudrias M; Garant MP
    Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of brain metastases from lung cancer: chemotherapy.
    Schuette W
    Lung Cancer; 2004 Aug; 45 Suppl 2():S253-7. PubMed ID: 15552807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thrill of victory; the agony of defeat.
    Turrisi AT
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1300-2. PubMed ID: 18374219
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of intensive chemotherapy in the treatment of medulloblastoma/primitive neuroectodermal tumor in children].
    Konoplia NE; Strongin IuS; Talabaev MV; Aleĭnikova OV
    Vopr Onkol; 2008; 54(2):157-63. PubMed ID: 18522163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemotherapy of high-grade astrocytomas.
    Lesser GJ; Grossman S
    Semin Oncol; 1994 Apr; 21(2):220-35. PubMed ID: 8153666
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose combination chemotherapy: why, how, and when.
    Israël L
    Mt Sinai J Med; 1985 Jun; 52(6):447-51. PubMed ID: 3875024
    [No Abstract]   [Full Text] [Related]  

  • 11. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma].
    Jeremić B; Grujicić D; Matović M
    Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
    Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the blood-brain barrier relevant in metastatic germ cell tumor?
    Azar JM; Schneider BP; Einhorn LH
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):163-6. PubMed ID: 17707269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic analysis and individualized therapy for diffuse glioma].
    Watanabe T; Yoshino A; Katayama Y
    No Shinkei Geka; 2005 Jun; 33(6):537-53. PubMed ID: 15952303
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of brain metastases.
    Korfel A; Thiel E
    Front Radiat Ther Oncol; 1999; 33():343-8. PubMed ID: 10549505
    [No Abstract]   [Full Text] [Related]  

  • 17. [Temporary hyperosmolar breakage of the blood-brain barrier improves effectiveness of chemotherapy for cerebral tumors].
    Aronov MS; Kobiakov GL; Lubnin AIu; Iakovlev SB
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (3):52-9. PubMed ID: 19062597
    [No Abstract]   [Full Text] [Related]  

  • 18. Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Galor A; Ference SJ; Singh AD; Lee MS; Stevens GH; Perez VL; Peereboom DM
    Am J Ophthalmol; 2007 Jul; 144(1):45-49. PubMed ID: 17601426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
    Chamberlain MC; Glantz MJ
    Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug cocktails for effective treatment of glioblastoma multiforme.
    Debinski W
    Expert Rev Neurother; 2008 Apr; 8(4):515-7. PubMed ID: 18416653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.